Viemed Healthcare, Inc. (VMD): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$28.61M
Year ended 2025-12-31
$30.25M
Trailing 12 months to 2026-06-30
+22.3%
3-year compound annual growth
2022-12-31: $15.63M2023-12-31: $21.86M2024-12-31: $25.37M2025-12-31: $28.61M$28.61M
2022-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$28.61M+12.8%2026-03-04, From 2025-01-01
2024-12-31$25.37M+16.0%2026-03-04, From 2024-01-01
2023-12-31$21.86M+39.9%2026-03-04, From 2023-01-01
2022-12-31$15.63Mn/a2025-03-10, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Viemed Healthcare, Inc. (VMD)2025-12-31$28.61M+12.8%
Sotera Health Co (SHC)2025-12-31$94.90M+12.6%
Progyny, Inc. (PGNY)2025-12-31$4.95M+55.8%
Cryo Cell International Inc (CCEL)2025-11-30$751.5K+55.4%
Marpai, Inc. (MRAI)2025-12-31$381.0K-83.1%
agilon health, inc. (AGL)2025-12-31$28.59M+16.9%
Pacific Health Care Organization Inc (PFHO)2025-12-31$24.0K-29.7%
DaVita Inc. (DVA)2025-12-31$715.35M-1.2%
Mangoceuticals, Inc. (MGRX)2024-12-31$9.9K-60.1%

Compare VMD, SHC, PGNY, CCEL side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗